Quantcast

Landeskrankenhaus Feldkirch Will Bring New Hope to Cancer Patients in Western Austria With the Help of Elekta Technology and Software Solutions

February 6, 2007

Elekta (STO:EKTAB) , a world leader in advanced radiation treatment of cancer and brain disorders, today announced an order from Landeskrankenhaus Feldkirch, Austria. The order includes two Elekta Synergy(R), advanced treatment systems for intensity modulated and image guided radiation therapy (IMRT & IGRT). The order also includes MOSAIQ(TM), a comprehensive oncology information management software suit from IMPAC Medical Systems, an Elekta company. The total contract is valued at over 8 MEUR and includes a service contract spanning over the equipments entire expected lifetime.

The radiation oncology department at Landeskrankenhaus Feldkirch is offering high level radiation therapy for about 1,000 patients annually. With the installation of the two new Elekta Synergy systems equipped with integrated high-resolution 3D X-ray volume imaging capability for IGRT along with advanced IMRT, the radiation oncology department in Feldkirch will be able to offer these new and innovative methods for irradiating tumors with extremely high precision and accuracy. The initial order was booked by Elekta in January, and the installation will begin near the end of 2007.

The hospital will also install MOSAIQ, a comprehensive oncology information management solution, on more than 30 workstations, allowing oncologists and radiation therapists at the hospital to streamline its processes and seamlessly share information entered into the electronical medical records. MOSAIQ will optimize the radiation oncology workflow and support retrieval and management of data stored by the hospital departments as needed for advanced radiation therapy. It will be the first installation of this kind of oncology information software system for a regional cancer center in Austria.

“Elekta can provide us not only with the most advanced equipment for IGRT but also with the state-of-the-art information system needed to provide the highest level of patient care and departmental efficiency,” said Landeskrankenhaus Feldkirch new chief of radiotherapy Alexander DeVries, MD, PhD. Elmar Hillbrand, PhD, chief medical physicist, continues “through signing a long term service contract with Elekta the hospital can assure efficient and up-and-running department that will benefit cancer patients in western Austria”.

The Landeskrankenhaus Feldkirch, a 660-bed-hospital, is the main regional health care center for the Austrian Federal State of Vorarlberg. The hospital serves an area of about 400,000 inhabitants in the westernmost state of Austria bordering Liechtenstein, Switzerland and Germany.

“We are very pleased and proud that Landeskrankenhaus Feldkirch turned to us when it was time to upgrade its cancer care capacity. We have seen an increasing interest in our IMPAC software system from customers in this part of Europe, and together with our advance technology for radiation therapy of cancer we can offer a total solution meeting the needs of a modern cancer clinic that aims for providing first class care”, said Dr. Emil Hensler, Business Unit Manager Elekta Austria.

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife(R) for non-invasive treatment of brain disorders and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world’s largest supplier of oncology software.

Elekta’s systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 2,000 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com and for more information about IMPAC Medical System please visit www.impac.com.

This information was brought to you by Waymaker http://www.waymaker.net




comments powered by Disqus